PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Latest blood cancer treatment updates presented at annual NCCN event during Blood Cancer Awareness Month

NCCN 2023 Annual Congress: Hematologic Malignancies features expert perspectives on developments in blood cancer treatment, including NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) updates, CAR T-cell therapy, BTK inhibitors, and more

2023-09-18
(Press-News.org) SAN FRANCISCO, CA [September 18, 2023] — The National Comprehensive Cancer Network® (NCCN®) 2023 Annual Congress: Hematologic Malignancies™ returns to San Francisco this week, for the first time since 2019. The meeting features insights from world-renowned experts on providing optimal, evidence-based treatment for various blood cancers, plus best practices for protecting vulnerable populations in a changing healthcare landscape.

The live event is taking place September 22-23, 2023, at the Hilton San Francisco Union Square. For full details and to register, visit NCCN.org/hem.

“We designed a comprehensive program for the entire hematology and oncology team—taking into account the latest advances, conversations, and controversies in blood cancer treatment today,” said congress Chair Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center. “Attendees from all over the world can learn about the most up-to-date evidence and expert consensus for improving outcomes for patients with a variety of hematologic malignancies. The event also provides opportunities for networking and questions with leading experts in the field.”

The hybrid event is back in California for the first time in four years, following last year’s meeting in New York City. Attendees are also able to attend live online via NCCN’s easy-to-use virtual platform. Sessions will remain accessible on-demand for 60 days following the event for all registrants.

Some of this year’s featured topics include:

Identifying and managing toxicities in patients receiving CAR T-cell therapy Revolutionizing hematologic cancer treatment with bispecific T-cell engagers Integrating new WHO/ICC classification systems Tackling inequities in access and quality of care for patients with multiple myeloma Managing graft-versus-host disease in transplant recipients Prevention and management of blood clots Speakers will also share information and research pertaining to the treatment of Adult Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), B-Cell Malignancies, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Chronic Myeloid Leukemia, Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), Multiple Myeloma (MM), Myelodysplastic Syndromes (MDS), Myelofibrosis (MF), and Waldenström Macroglobulinemia (WM).

“This conference seeks to provide clear, understandable, and actionable updates to help busy care providers analyze, evaluate, and contextualize new clinical data,” said Wui-Jin Koh, MD, Senior Vice President, Chief Medical Officer, NCCN. “This will help us all to achieve the best possible outcomes for people with blood cancer in a rapidly evolving landscape.”

Save the dates: the NCCN 2024 Annual Conference will be happening in Orlando, FL April 5 - 7, 2024. Visit NCCN.org/conference for more information.

# # #

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information

END



ELSE PRESS RELEASES FROM THIS DATE:

How do suicide risk or depression screenings compare to identify patients at risk?

2023-09-18
Editor’s Note: September is National Suicide Prevention Month.   COLUMBUS, Ohio – Research led by The Ohio State University Wexner Medical Center and Wesleyan University found that depression screening tools outperformed suicide risk screenings under most conditions.  “We compared the effectiveness of multiple depression and suicide risk screening methods for the purpose of identifying primary care patients who subsequently attempted suicide. Our findings may generate a lot of discussion within the suicide prevention community, as it contradicts long-held assumptions ...

Atomic layer deposition route to scalable, electronic-grade van der Waals Te thin films

Atomic layer deposition route to scalable, electronic-grade van der Waals Te thin films
2023-09-18
A research team, led by Professor Joonki Suh in the Department of Materials Science and Engineering and the Graduate School of Semiconductor Materials and Devices Engineering at UNIST, has made a significant breakthrough in thin film deposition technology. By employing an innovative atomic layer deposition (ALD) process, Professor Seo successfully achieved regular arrangement of tellurium (Te) atoms at low temperatures as low as 50 degrees Celsius. The ALD method is a cutting-edge thin film process that enables precise stacking ...

NIH launches $2 million prize competition to spur innovation in fetal diagnostic and monitoring technologies

NIH launches $2 million prize competition to spur innovation in fetal diagnostic and monitoring technologies
2023-09-18
The National Institutes of Health will award up to $2 million in cash prizes to accelerate development of diagnostic and monitoring technologies that improve fetal health outcomes in low-resource settings. The Rapid Acceleration of Diagnostics Technology (RADx® Tech) Fetal Monitoring Challenge calls on scientists, engineers, and clinicians around the country to submit their innovative approaches and compete for prizes and additional resources to support technology development and clinical impact. The challenge is sponsored by the NIH’s National Institute of Biomedical Imaging and Bioengineering (NIBIB), ...

Incubator or barrier? Exploring the links between agriculture, biodiversity and the spread of pathogens

2023-09-18
Many pathogens, including the virus that causes COVID-19, are thought to have originated in wild animals before spilling into human populations. Agriculture is often blamed for accelerating this process, which is known as zoonotic spillover, through deforestation and habitat fragmentation that reduce biodiversity and increase the likelihood of contact between infected wildlife and humans. But in a Perspectives article published online Sept. 15 in the journal One Earth, University of Michigan ecologist Ivette Perfecto and her colleagues argue that agriculture can both help and hinder: ...

FAU receives $750,000 philanthropic grant for Alzheimer’s disease

FAU receives $750,000 philanthropic grant for Alzheimer’s disease
2023-09-18
More than 720,000 Floridians will be living with Alzheimer’s disease by 2025. Currently, Florida has the second highest prevalence of Alzheimer’s disease in the United States and is the sixth leading cause of death in Floridians 65 and older. Although the epidemic of age-related brain dysfunction – of which Alzheimer’s disease is a major factor –  is growing at an alarming rate, there is a disconnect between the existing care model designed for urgent care and the progressive nature of this chronic condition, which tends to worsen over time. To address this widespread health concern, Florida Atlantic University’s Schmidt College ...

Study shows nearly 300% increase in ADHD medication errors

2023-09-18
(COLUMBUS, Ohio) – Attention-deficit/hyperactivity disorder (ADHD) is among the most common pediatric neurodevelopmental disorders. In 2019, nearly 10% of United States (U.S.) children had a diagnosis of ADHD. Approximately 3.3 million children, or roughly 5 out of every 100 children in the U.S., are currently prescribed medication for ADHD. In a new study, published today in Pediatrics, researchers at the Center for Injury Research and Policy and Central Ohio Poison Center at Nationwide Children’s Hospital investigated the characteristics ...

KICT develops road pothole filtering program based on AI

KICT develops road pothole filtering program based on AI
2023-09-18
The Korea Institute of Civil Engineering and Building Technology (KICT, President Kim Byung-Suk) has developed a 'Road Pothole Filtering Program' to establish an emergency road restoration system for frequent pothole occurrences. Commonly referred to as 'the landmine of the road,' potholes are a road damage phenomenon in which parts of the asphalt sink into bowl-like depressions. Potholes occur when a significant amount of rainwater infiltrates the road surface, weakening the ground below and causing the asphalt ...

New online tool available to help health care providers identify a hard to diagnose breast cancer

2023-09-18
A new diagnostic scoring system, developed by renowned breast cancer experts, is now available as an easy-to-use online tool through Susan G. Komen®, the world’s leading breast cancer organization. This tool will help health care providers recognize and effectively diagnose a rare and aggressive breast cancer, inflammatory breast cancer. The new Inflammatory Breast Cancer (IBC) Scoring System online tool is available at https://www.komen.org/ibc and may help to increase diagnostic accuracy, predict outcomes, guide treatment decisions ...

Pearl Harbor: Bombed battleships’ boost for climate science

Pearl Harbor: Bombed battleships’ boost for climate science
2023-09-18
Weather data from several ships bombed by Japanese pilots at Pearl Harbor has been recovered in a rescue mission that will help scientists understand how the global climate is changing.  Crew members aboard various vessels - such as the USS Pennsylvania and the USS Tennessee - died when their battleships were targeted in December 1941. Despite these losses, many boats returned to service during the Second World War and US naval servicemen continued their daily duties, which included recording weather data.   A new research paper, published in Geoscience Data ...

Brigham researchers uncover ‘circular logic’ of RNAs in Parkinson’s disease

Brigham researchers uncover ‘circular logic’ of RNAs in Parkinson’s disease
2023-09-18
Investigators found and catalogued mysterious RNA circles that are linked to brain cell identity Findings show that circular RNA is produced by brain cells damaged in Parkinson’s and Alzheimer’s disease Circular RNA production from one Parkinson’s gene DNAJC6 was abnormal even prior to symptom onset Researchers are gaining new insights into neurological diseases by studying circular RNAs (circRNAs) in brain cells. A new study by investigators from the Brigham and Women’s Hospital, a founding member of the Mass General ...

LAST 30 PRESS RELEASES:

12.5, the 1st Impact Factor of COMMTR released!

Circadian clock impact on cluster headaches funded by $2.4M NIH grant for UTHealth Houston research

Study identifies first drug therapy for sleep apnea

How old is your bone marrow?

Boosting biodiversity without hurting local economies

ChatGPT is biased against resumes with credentials that imply a disability — but it can improve

Simple test for flu could improve diagnosis and surveillance

UT Health San Antonio researcher awarded five-year, $2.53 million NIH grant to study alcohol-assisted liver disease

Giving pre-med students hands-on clinical training

CAMH research suggests potential targets for prevention and early identification of psychotic disorders

Mapping the heart to prevent damage caused by a heart attack

Study challenges popular idea that Easter islanders committed ‘ecocide’

Chilling discovery: Study reveals evolution of human cold and menthol sensing protein, offering hope for future non-addictive pain therapies.

Elena Beccalli, new rector of Università Cattolica del Sacro Cuore, takes office on 1st July

Pacific Northwest Research Institute uncovers hidden DNA mechanisms of rare genetic diseases

Empowering older adults: Wearable tech made easier with personalized support

Pennington Biomedical researchers partner on award-winning Long Covid study

Cooling ‘blood oranges’ could make them even healthier – a bonus for consumers

Body image and overall health found important to the sexual health of older gay men, according to new studies

Lab-grown muscles reveal mysteries of rare muscle diseases

Primary hepatic angiosarcoma: Treatment options for a rare tumor

Research finds causal evidence tying cerebral small-vessel disease to Alzheimer’s, dementia

Navigating the Pyrocene: Recent Cell Press papers on managing fire risk

Restoring the Great Salt Lake would have environmental justice as well as ecological benefits

Cannabis, tobacco use, and COVID-19 outcomes

A 5:2 intermittent fasting meal replacement diet and glycemic control for adults with diabetes

Scientists document self-propelling oxygen decline in the oceans

Activating molecular target reverses multiple hallmarks of aging

Cannabis use tied to increased risk of severe COVID-19

How to make ageing a ‘fairer game’ for all wormkind

[Press-News.org] Latest blood cancer treatment updates presented at annual NCCN event during Blood Cancer Awareness Month
NCCN 2023 Annual Congress: Hematologic Malignancies features expert perspectives on developments in blood cancer treatment, including NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) updates, CAR T-cell therapy, BTK inhibitors, and more